Table 2.
Characteristic | Frequency | Percent | |
---|---|---|---|
Awareness of presence of AMR in Tanzania | |||
Yes | 39 | 100.0 | |
No | 0 | 0 | |
Awareness of presence of The NAP on AMR 2017–2022 in Tanzania | |||
No | 13 | 33.3 | |
Yes | 26 | 66.7 | |
Presence of an ASP committee on AMR in the facility | |||
No | 25 | 64.1 | |
Yes | 14 | 35.9 | |
Does the AMR committee have either of the following?* | |||
Medical doctor | 9 | 23.1 | |
Pharmacist | 10 | 25.6 | |
Medical laboratory scientist | 8 | 20.5 | |
Pharmacologist | 1 | 2.6 | |
Microbiologist | 4 | 10.3 | |
Nurse | 6 | 15.4 | |
Environmental scientist | 3 | 7.7 | |
Pathologist | 1 | 2.6 | |
AMR awareness and education to health workers at the facility | |||
No | 12 | 30.8 | |
Yes | 27 | 69.2 | |
Presence of Antimicrobial resistance levels/surveillance report at | |||
your facility | |||
No | 32 | 82.1 | |
Yes | 7 | 17.9 | |
Organisms under AMR surveillance at your facility* | |||
Escherichia coli | 6 | 15.4 | |
Staphylococcus aureus | 4 | 10.3 | |
Klebsiella pneumonia | 3 | 7.7 | |
Acinetobacter baumannii | 0 | 0.0 | |
Pseudomonas aeruginosa | 2 | 5.1 | |
Enterococci species | 1 | 2.6 | |
Clostridium dificcile | 1 | 2.6 | |
Candida species | 1 | 2.6 | |
Presence of a software to record antimicrobial susceptibility results | |||
No | 30 | 76.9 | |
Yes | 9 | 23.1 | |
Presence of any antimicrobial use report in the facility | |||
No | 30 | 76.9 | |
Yes | 9 | 23.1 | |
Where do you share/send the feedback or report on | |||
Antimicrobial use?* | |||
District medical officer | 5 | 12.8 | |
Regional medical officer | 2 | 5.1 | |
Ministry of health | 2 | 5.1 | |
Health care providers at the health center | 1 | 2.6 | |
Medical director of the hospital | 1 | 2.6 | |
Therapeutic committee | 1 | 2.6 |
, Multiple responses were available for the question; ASP, antimicrobial stewardship program; AMR, antimicrobial resistance; NAP, national action plan.